Our research team, led by Dr. Rose Khavari, has demonstrated for the first time that functional MRI can be used to capture real-time activity in the human spinal cord regions responsible for bladder control.

Patients with a particularly aggressive form of metastatic colorectal cancer may benefit from a novel combination of targeted therapy and immunotherapy, according to a Houston-led phase 1/2 clinical trial.

We recruited internationally recognized cardiologist @drmarthagulati.bsky.social to lead our new Davis Women’s Heart Center, marking a major investment in the prevention, diagnosis and treatment of heart disease in women.

Three interconnected areas of research, led by Drs. Dimitry Sayenko, Amir Faraji and Sean Barber, are combining peripheral transfers, bioelectronics, transcutaneous spinal cord stimulation and other technologies to advance SCI treatments.

We've received FDA approval for Gallium Ga 68 Edotreotide Injection, an advanced imaging agent that helps physicians more precisely detect certain neuroendocrine tumors. This milestone makes us the 2nd center in the nation to receive approval for a diagnostic agent of this kind.

In contrast to pediatric-based models, our ACHD Program operates entirely in an adult heart hospital setting — improving continuity for adult complications without fragmented handoffs.

One of the great barriers to outstanding U.S. health care is limited English proficiency. Learn more about how our innovative technology is breaking down those walls.

Two new studies led by our hepatologist Dr. Mazen Noureddin provide the strongest evidence to date that cirrhosis caused by metabolic dysfunction-associated steatohepatitis (MASH) may be reversible — a milestone once considered unattainable in hepatology.

Assistant Professor of Neurosurgery Dr. Amir Faraji is developing new techniques and methodologies to improve patient outcomes for neurodegenerative diseases.

Physician-researchers Dr. Stanley Appel and Aaron Thome have made significant progress unraveling the mechanics of amyotrophic lateral sclerosis (ALS) and Parkinson’s and Alzheimer’s diseases.

An artificial intelligence-driven wearable device may offer a meaningful, noninvasive treatment option for people with essential tremor, according to a study led by our Professor of Neurology Dr. William Ondo.

Recent advances in spinal stimulation research are reshaping how clinicians and scientists understand recovery potential after spinal cord injury, thanks in part to a series of studies led by our Associate Professor in Neurosurgery Dr. Dimitry Sayenko.

A new multicenter study, led by our researchers and Rice University researchers, has identified four distinct patient profiles in aortic regurgitation.

Learn more about how we're using artificial intelligence-enabled virtual care platforms and embedded sensors to make our hospital rooms self-aware care spaces.

A new interdisciplinary project led by Rice University and our Research Institute aims to clarify how the brain adapts to neural implants over time.

Our new study offers a clearer picture of how Alzheimer's disease may influence the body far beyond the brain — specifically by interfering with the way nerves and blood vessels communicate inside fat tissue.

Orbital decompression surgery has declined significantly since the Food and Drug Administration's 2020 approval of the biologic teprotumumab, according to a national analysis led by Drs. Omar Ahmed and Amina Malik.

In a recent published review, Chief of Gastroenterology Dr. Eamonn Quigley is calling for a fundamental reset in how scientific and medical communities — and the public — think about probiotics, the increasingly trendy intervention for some gut problems.

In a comprehensive recent review article, our Chief of Gastroenterology Dr. Eamonn Quigley examines how the gut microbiome and its metabolic products contribute to irritable bowel syndrome — and where misconceptions continue to cloud the field.

New findings from our team, led by Drs. Hongbo Gao and Keith Syson Chan, suggest that chemo-induced cell death might also release signals that promote drug resistance.

The diagnosis of small intestinal bacterial overgrowth (SIBO) has undergone a major conceptual drift — and not necessarily for the better, according to a recent review by our Chief of Gastroenterology Dr. @eamonnquigleymd. spr.ly/633237ngkb

More than a century after Pavlov's dog established the role of external cues in associative learning, our researchers have discovered that the brain can internalize and replay rhythms of stimulation even without reward, meaning or a conditioned signal.

We're working to take patient surveying to the next level by developing future technology that will yield even more useful predictive analytic models.

A new review, led by Chair of Obstetrics and Gynecology Dr. Pedro Ramirez, recommends a shift from one-size-fits-all surgical practices to a more risk-adapted, patient-specific approach to treating early-stage cervical cancer.

The Houston Methodist–Rice Digital Health Institute have formally launched, underscoring the institutions' shared vision to serve as a translational engine for an industry where data, artificial intelligence, engineering and medicine converge.

Our researchers, led by Dr. Muralidhar L. Hegde, have uncovered a novel role for the RNA/DNA-binding protein TDP43, showing that it directly regulates DNA mismatch repair genes — a finding that could reshape understanding of both neurodegenerative disease and cancer.

Researchers at our Academic Institute, led by Dr. Stefano Casarin, have unveiled a groundbreaking computational model that could transform how scientists study and treat bone metastasis, one of the deadliest complications of advanced cancers.

Dubbed the hospital of the future, our Cypress Hospital represents an investment in improving patient care, hospital efficiency and the day-to-day workloads of doctors and nurses.

Our Chief of Cardiovascular Disease Prevention and Wellness Dr. Khurram Nasir recently appeared on @houstonpublicmedia.bsky.social's "Hello Houston" to discuss the Houston Methodist-Rice University Digital Health Institute and their work to shape the future of digital health.

In this episode of Quality Time with Dr. Shlomit Schaal, nursing leaders Gail M. Vozzella and Caroline Mascarenhas discuss how virtual nursing and innovative technology have improved patient safety and more.

After successfully bringing ambient listening into our outpatient settings, we’re now piloting the use of the clinical voice technology in new territory: the emergency department and in-patient care.

Our first-of-its-kind study found that adipose-derived extracellular vesicles can signal the buildup of amyloid-β plaque—a key feature of Alzheimer’s disease—in obese individuals.

Neuroinflammation is linked to a host of detrimental brain disorders. A recently published study, led by Dr. Robert Krencik, reveals the creation of AstroCapsules, a tiny, bioengineered system to deliver human astrocytes to specific targets in the brain. Read more in the Independent.

A recent study, co-authored by our orthopedic surgeon Dr. Sachin Allahabadi, shows that underwater reaming preserves 10-13% more viable chondrocytes, potentially leading to better long-term outcomes for patients undergoing knee cartilage repair.

Elimination diets guided by a novel immunoglobulin G (IgG) food sensitivity test can reduce abdominal pain and improve symptoms in patients with IBS, according to a study co-authored by our Chief of Gastroenterology Dr. Eamonn Quigley.

We've joined forces with the @utmbhealth.bsky.social on a transformative new initiative—the Greater Gulf Coast Translational Science Alliance - to accelerate the translation of groundbreaking scientific discoveries into real-world health improvements across the Gulf Coast region.

The Houston Methodist program deploys virtual hospitalists to deliver care to patients admitted overnight when there are fewer hospitalists on site.

A new study, co-authored by our Chief of Gastroenterology Dr. Eamonn Quigley, aims at helping clinicians better implement findings from decades-long research that has increased the understanding of IBS' pathophysiology.

Some of our most rewarding innovations don't involve high tech. From thoughtful anticipation of needs to personalized dining options, we’re rewriting what patient comfort means in the hospital.

Our hepatologist Dr. @NoureddinMD will discuss non-invasive testing for liver disease at #TSGE2025.

A vaccine, developed through a partnership between the @houstonzoo.bsky.social and @bcmhouston.bsky.social, and manufactured by our RNACore, has proven effective in helping two young elephants from @cincinnatizoo.bsky.social recover from Elephant Endotheliotropic Herpesvirus (EEHV).

With Dr. Jason Ahuero as our PI, we're one of three clinical sites in the U.S. participating in an international Phase II trial evaluating an alternative approach to treating mid-portion Achilles tendinopathy using locally delivered microspheres.

As humanity pushes the boundaries of space exploration, our researchers, led by Dr. Mas Takashima, are helping answer a surprisingly down-to-earth question: What happens to your sinuses in space?

According to our recent study, led by Head of Thoracic Surgery Dr. Min Kim, surgical resection may significantly improve outcomes in patients with a single colorectal lung metastasis.

According to our new study with the Houston Ballet, led by Associate Professor of Orthopedic Surgery Dr. Comron Saifi, female ballet dancers disproportionately have idiopathic scoliosis.

Our researchers, led by Dr. Valentin Dragoi, have developed an optogenetic modulation protocol by which scientists selectively control neural connections to study how distinct brain areas interact to generate attention, perception and decision-making.

Our pioneers, Drs. David Victor and Nakul Gupta, unveiled a new short-sequence MRI protocol that diagnoses metabolic-associated steatotic liver disease (MASLD) with fibrosis in just 5 to 10 minutes.

According to our study co-led by Drs. Mas Takashima and Omar Ahmed, sustained weight loss significantly reduces the risk, symptoms and treatment burden of chronic rhinosinusitis.

In this episode of Quality Time with Dr. Shlomit Schaal, Dr. Terence Flotte, dean of the UMass Chan Medical School, discusses educating the next generation of physician leaders and more.

According to a trial led by our professor of urology Dr. Rose Khavari, patients with overactive bladder and urinary incontinence experience significantly less pain and just as much symptom relief when receiving fewer bladder injections of Botox.